Auxilio Mutuo Hospital Selects Oracle Health's EHR to Improve Patient Experience
Get Alerts ORCL Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.7%
Revenue Growth %: +28.1%
Join SI Premium – FREE
Adds Oracle Health RevElate to help boost operational efficiency and streamline billing processes across the hospital
"With the ever-changing healthcare environment, we need a vendor that matches Auxilio Mutuo's clinical experience and offers a robust electronic health records system," said
Oracle Health's first customer in
As the health system continues to rebuild and expand, its new Oracle Health EHR will provide a stable and secure system to help Auxilio Mutuo's care teams make more informed decisions when it matters most. The EHR can also reduce administrative tasks to help drive efficiency while helping improve patient care and experiences.
"Auxilio Mutuo provides a textbook example of how strategic technology deployments and innovation can enhance the clinician and patient experience with the goal to ultimately help improve health and financial outcomes," said
Visit our website to learn more about how Oracle is advancing healthcare.
About Auxilio Mutuo
Auxilio Mutuo Hospital is a general and specialized services, private, non-profit institution that has been providing healthcare services to the population of
About Oracle
Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com.
Trademarks
Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.
View original content to download multimedia:https://www.prnewswire.com/news-releases/auxilio-mutuo-hospital-selects-oracle-healths-ehr-to-improve-patient-experience-302121465.html
SOURCE Oracle Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Next Level Performance Marks 50 Years of Impact with HOPE Week
- TIER IV joins Open Invention Network 2.0 to drive the expansion of the open-source ecosystem for autonomous driving through a patent strategy
- Ipsen completes acquisition of Kartos Therapeutics, strengthening late-stage Oncology pipeline
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share